Presage and Millennium unite to develop cancer drug combos

04/8/2012 | Mass High Tech (Boston)

Presage Biosciences and Millennium: The Takeda Oncology Co. signed a research deal to identify novel cancer drug combinations for treatment of solid tumors. The agreement gives Millennium access to Presage's technology that allows multiple threads of drug candidates to be placed directly into a tumor. Presage will receive an upfront payment and research funding, plus development and regulatory milestone fees.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC